Citation: Ep. Brass, Implementation of a data and safety monitoring program in a General Clinical Research Center, J INVES MED, 49(6), 2001, pp. 479-485
Authors:
Brass, EP
Hiatt, WR
Gardner, AW
Hoppel, CL
Citation: Ep. Brass et al., Decreased NADH dehydrogenase and ubiquinol-cytochrome c oxidoreductase in peripheral arterial disease, AM J P-HEAR, 280(2), 2001, pp. H603-H609
Authors:
Brass, EP
Adler, S
Sietsema, KE
Hiatt, WR
Orlando, AM
Amato, A
Citation: Ep. Brass et al., Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients, AM J KIDNEY, 37(5), 2001, pp. 1018-1028
Citation: Ep. Brass, Drug therapy: Changing the status of drugs from prescription to over-the-counter availability., N ENG J MED, 345(11), 2001, pp. 810-816
Authors:
Ulrich, RG
Bacon, JA
Brass, EP
Cramer, CT
Petrella, DK
Sun, EL
Citation: Rg. Ulrich et al., Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon, CHEM-BIO IN, 134(3), 2001, pp. 251-270
Citation: Ep. Brass et al., Multiple skeletal muscle mitochondrial DNA deletions in patients with unilateral peripheral arterial disease, VASC MED, 5(4), 2000, pp. 225-230
Authors:
Bauer, TA
Regensteiner, JG
Brass, EP
Hiatt, WR
Citation: Ta. Bauer et al., Oxygen uptake kinetics during exercise are slowed in patients with peripheral arterial disease, J APP PHYSL, 87(2), 1999, pp. 809-816
Citation: H. Wang et al., Relationships between muscle mitochondrial DNA content, mitochondrial enzyme activity and oxidative capacity in man: alterations with disease, EUR J A PHY, 80(1), 1999, pp. 22-27
Citation: Hk. Bhat et al., Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease, CIRCULATION, 99(6), 1999, pp. 807-812